2022-11-012024-03-312024-03-31false13678038JAISWAL RHINOLOGY LTD2024-07-30iso4217:GBPxbrli:pure136780382022-11-01136780382024-03-31136780382022-11-012024-03-31136780382021-10-13136780382022-10-31136780382021-10-132022-10-3113678038bus:SmallEntities2022-11-012024-03-3113678038bus:AuditExempt-NoAccountantsReport2022-11-012024-03-3113678038bus:FullAccounts2022-11-012024-03-3113678038bus:PrivateLimitedCompanyLtd2022-11-012024-03-3113678038core:WithinOneYear2024-03-3113678038core:AfterOneYear2024-03-3113678038core:WithinOneYear2022-10-3113678038core:AfterOneYear2022-10-3113678038core:ShareCapital2024-03-3113678038core:SharePremium2024-03-3113678038core:RevaluationReserve2024-03-3113678038core:OtherReservesSubtotal2024-03-3113678038core:RetainedEarningsAccumulatedLosses2024-03-3113678038core:ShareCapital2022-10-3113678038core:SharePremium2022-10-3113678038core:RevaluationReserve2022-10-3113678038core:OtherReservesSubtotal2022-10-3113678038core:RetainedEarningsAccumulatedLosses2022-10-3113678038core:LandBuildings2024-03-3113678038core:PlantMachinery2024-03-3113678038core:Vehicles2024-03-3113678038core:FurnitureFittings2024-03-3113678038core:OfficeEquipment2024-03-3113678038core:NetGoodwill2024-03-3113678038core:IntangibleAssetsOtherThanGoodwill2024-03-3113678038core:ListedExchangeTraded2024-03-3113678038core:UnlistedNon-exchangeTraded2024-03-3113678038core:LandBuildings2022-10-3113678038core:PlantMachinery2022-10-3113678038core:Vehicles2022-10-3113678038core:FurnitureFittings2022-10-3113678038core:OfficeEquipment2022-10-3113678038core:NetGoodwill2022-10-3113678038core:IntangibleAssetsOtherThanGoodwill2022-10-3113678038core:ListedExchangeTraded2022-10-3113678038core:UnlistedNon-exchangeTraded2022-10-3113678038core:LandBuildings2022-11-012024-03-3113678038core:PlantMachinery2022-11-012024-03-3113678038core:Vehicles2022-11-012024-03-3113678038core:FurnitureFittings2022-11-012024-03-3113678038core:OfficeEquipment2022-11-012024-03-3113678038core:NetGoodwill2022-11-012024-03-3113678038core:IntangibleAssetsOtherThanGoodwill2022-11-012024-03-3113678038core:ListedExchangeTraded2022-11-012024-03-3113678038core:UnlistedNon-exchangeTraded2022-11-012024-03-3113678038core:MoreThanFiveYears2022-11-012024-03-3113678038core:Non-currentFinancialInstruments2024-03-3113678038core:Non-currentFinancialInstruments2022-10-3113678038dpl:CostSales2022-11-012024-03-3113678038dpl:DistributionCosts2022-11-012024-03-3113678038core:LandBuildings2022-11-012024-03-3113678038core:PlantMachinery2022-11-012024-03-3113678038core:Vehicles2022-11-012024-03-3113678038core:FurnitureFittings2022-11-012024-03-3113678038core:OfficeEquipment2022-11-012024-03-3113678038dpl:AdministrativeExpenses2022-11-012024-03-3113678038core:NetGoodwill2022-11-012024-03-3113678038core:IntangibleAssetsOtherThanGoodwill2022-11-012024-03-3113678038dpl:GroupUndertakings2022-11-012024-03-3113678038dpl:ParticipatingInterests2022-11-012024-03-3113678038dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-012024-03-3113678038core:ListedExchangeTraded2022-11-012024-03-3113678038dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-012024-03-3113678038core:UnlistedNon-exchangeTraded2022-11-012024-03-3113678038dpl:CostSales2021-10-132022-10-3113678038dpl:DistributionCosts2021-10-132022-10-3113678038core:LandBuildings2021-10-132022-10-3113678038core:PlantMachinery2021-10-132022-10-3113678038core:Vehicles2021-10-132022-10-3113678038core:FurnitureFittings2021-10-132022-10-3113678038core:OfficeEquipment2021-10-132022-10-3113678038dpl:AdministrativeExpenses2021-10-132022-10-3113678038core:NetGoodwill2021-10-132022-10-3113678038core:IntangibleAssetsOtherThanGoodwill2021-10-132022-10-3113678038dpl:GroupUndertakings2021-10-132022-10-3113678038dpl:ParticipatingInterests2021-10-132022-10-3113678038dpl:GroupUndertakingscore:ListedExchangeTraded2021-10-132022-10-3113678038core:ListedExchangeTraded2021-10-132022-10-3113678038dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-10-132022-10-3113678038core:UnlistedNon-exchangeTraded2021-10-132022-10-3113678038core:NetGoodwill2024-03-3113678038core:IntangibleAssetsOtherThanGoodwill2024-03-3113678038core:LandBuildings2024-03-3113678038core:PlantMachinery2024-03-3113678038core:Vehicles2024-03-3113678038core:FurnitureFittings2024-03-3113678038core:OfficeEquipment2024-03-3113678038core:AfterOneYear2024-03-3113678038core:WithinOneYear2024-03-3113678038core:ListedExchangeTraded2024-03-3113678038core:UnlistedNon-exchangeTraded2024-03-3113678038core:ShareCapital2024-03-3113678038core:SharePremium2024-03-3113678038core:RevaluationReserve2024-03-3113678038core:OtherReservesSubtotal2024-03-3113678038core:RetainedEarningsAccumulatedLosses2024-03-3113678038core:NetGoodwill2022-10-3113678038core:IntangibleAssetsOtherThanGoodwill2022-10-3113678038core:LandBuildings2022-10-3113678038core:PlantMachinery2022-10-3113678038core:Vehicles2022-10-3113678038core:FurnitureFittings2022-10-3113678038core:OfficeEquipment2022-10-3113678038core:AfterOneYear2022-10-3113678038core:WithinOneYear2022-10-3113678038core:ListedExchangeTraded2022-10-3113678038core:UnlistedNon-exchangeTraded2022-10-3113678038core:ShareCapital2022-10-3113678038core:SharePremium2022-10-3113678038core:RevaluationReserve2022-10-3113678038core:OtherReservesSubtotal2022-10-3113678038core:RetainedEarningsAccumulatedLosses2022-10-3113678038core:NetGoodwill2021-10-1313678038core:IntangibleAssetsOtherThanGoodwill2021-10-1313678038core:LandBuildings2021-10-1313678038core:PlantMachinery2021-10-1313678038core:Vehicles2021-10-1313678038core:FurnitureFittings2021-10-1313678038core:OfficeEquipment2021-10-1313678038core:AfterOneYear2021-10-1313678038core:WithinOneYear2021-10-1313678038core:ListedExchangeTraded2021-10-1313678038core:UnlistedNon-exchangeTraded2021-10-1313678038core:ShareCapital2021-10-1313678038core:SharePremium2021-10-1313678038core:RevaluationReserve2021-10-1313678038core:OtherReservesSubtotal2021-10-1313678038core:RetainedEarningsAccumulatedLosses2021-10-1313678038core:AfterOneYear2022-11-012024-03-3113678038core:WithinOneYear2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:CostValuation2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-012024-03-3113678038core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113678038core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113678038core:Non-currentFinancialInstrumentscore:CostValuation2022-10-3113678038core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-3113678038core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-3113678038core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-3113678038core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-3113678038core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-3113678038core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-3113678038core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-3113678038core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-3113678038bus:Director12022-11-012024-03-3113678038core:FurnitureFittingsToolsEquipment2022-10-3113678038core:FurnitureFittingsToolsEquipment2022-11-012024-03-3113678038core:FurnitureFittingsToolsEquipment2024-03-31

JAISWAL RHINOLOGY LTD

Registered Number
13678038
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2024

JAISWAL RHINOLOGY LTD
Company Information
for the period from 1 November 2022 to 31 March 2024

Director

JAISWAL, Archana, Dr

Registered Address

8 Agalia Gardens
Manchester
M20 2PZ

Registered Number

13678038 (England and Wales)
JAISWAL RHINOLOGY LTD
Balance Sheet as at
31 March 2024

Notes

31 Mar 2024

31 Oct 2022

£

£

£

£

Fixed assets
Tangible assets33,5362,819
3,5362,819
Current assets
Stocks41,706-
Debtors-3,616
Cash at bank and on hand24,9919,321
26,69712,937
Creditors amounts falling due within one year5(6,747)(4,174)
Net current assets (liabilities)19,9508,763
Total assets less current liabilities23,48611,582
Provisions for liabilities6(672)(536)
Net assets22,81411,046
Capital and reserves
Called up share capital100100
Profit and loss account22,71410,946
Shareholders' funds22,81411,046
The financial statements were approved and authorised for issue by the Director on 30 July 2024, and are signed on its behalf by:
JAISWAL, Archana, Dr
Director
Registered Company No. 13678038
JAISWAL RHINOLOGY LTD
Notes to the Financial Statements
for the period ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Fixtures and fittings15
Office Equipment25
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20242022
Average number of employees during the year11
3.Tangible fixed assets

Fixtures & fittings

Office Equipment

Total

£££
Cost or valuation
At 01 November 227262,9363,662
Additions7101,0491,759
At 31 March 241,4363,9855,421
Depreciation and impairment
At 01 November 22109734843
Charge for year1528901,042
At 31 March 242611,6241,885
Net book value
At 31 March 241,1752,3613,536
At 31 October 226172,2022,819
4.Stocks

2024

2022

££
Work in progress1,706-
Total1,706-
5.Creditors: amounts due within one year

2024

2022

££
Taxation and social security2,8592,974
Other creditors2,520-
Accrued liabilities and deferred income1,3681,200
Total6,7474,174
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Provisions for liabilities

2024

2022

££
Net deferred tax liability (asset)672536
Total672536